CNS Response, Inc. (OTCBB: CNSO) announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress. “Referenced-EEG (rEEG®) Efficacy Compared to Star*D for Patients with Depression Treatment Failure: First Look at Final Results,” will be presented by Charles DeBattista, M.D. on Monday, November 2nd, at 3:45 to 6:45 p.m.
Popularity: unranked [?]
Related posts:
- Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress
- Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress
- STAR*D, A Landmark Depression Study Releases Results
- STAR*D, A Landmark Depression Study Releases Results
- Ridge Diagnostics, Inc. Clinical Data On Blood Test For Depression Presented At American Psychiatric Association Annual Meeting
Comments
No Responses to “Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress”